The macrophage activation marker, soluble CD163 is associated with hepatic inflammation and fibrosis in chronic viral hepatitis C and declines during effective direct-acting antiviral therapy

2017 ◽  
Vol 66 (1) ◽  
pp. S742
Author(s):  
T.L. Laursen ◽  
C. Siggaard ◽  
K. Kazankov ◽  
T. Sandahl ◽  
H.J. Møller ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Viral Hepatitis ◽  
Macrophage Activation ◽  
Chronic Viral Hepatitis ◽  
Hepatic Inflammation ◽  
Direct Acting Antiviral ◽  
Soluble Cd163 ◽  
Viral Hepatitis C ◽  
Direct Acting ◽  
Chronic Viral Hepatitis C

Анализ отдаленной эффективности противовирусных препаратов прямого действия в терапии хронического вирусного гепатита С

2020 ◽  
pp. 14-17
Keyword(s):  
Hepatitis C ◽  
Viral Hepatitis ◽  
High Efficiency ◽  
Chronic Viral Hepatitis ◽  
Direct Acting Antiviral ◽  
Treatment Regimens ◽  
Viral Hepatitis C ◽  
Direct Acting ◽  
And Control ◽  
Chronic Viral Hepatitis C

Long-term efficacy of direct-acting antiviral drugs (DAAD) was evaluated in 44 patients with chronic viral hepatitis C who had been receiving therapy at the Khabarovsk and Kamchatka centers for the prevention and control of AIDS and infectious diseases from 2015 to 2018. The data were evaluated through a retrospective analysis of ambulatory patient records and control in the form of a qualitative detection of viral RNA by a highly sensitive PCR method. According to the results of the analysis, 41 out of 44 patients (93,18 %) managed to achieve a stable virological response (SVR 24), which remains stable at present (p<0,05). Three of the studied patients had a relapse, probably associated with incorrect treatment regimens and the presence of cogenotypes. The data obtained indicate a high efficiency of DAAD in the treatment of chronic viral hepatitis C in the Khabarovsk and Kamchatka territories.

scholarly journals Effectiveness of Treatment of Chronic Viral Hepatitis C by Direct-Acting Antivirals in Togo

2019 ◽  
Vol 09 (07) ◽  
pp. 125-133
Author(s):  
Laté Mawuli Lawson-Ananissoh ◽  
Aklesso Bagny ◽  
Oumboma Bouglouga ◽  
Laconi Kaaga ◽  
Rafiou El-Hadji Yakoubou ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Viral Hepatitis ◽  
Chronic Viral Hepatitis ◽  
Direct Acting Antivirals ◽  
Viral Hepatitis C ◽  
Direct Acting ◽  
Chronic Viral Hepatitis C

scholarly journals Assessment of adherence to chronic viral hepatitis C treatment in Romania: an open, single center, prospective study

2016 ◽  
Vol 2 (2) ◽  
pp. 59-68
Author(s):  
Anca Streinu-Cercel ◽  
Maria-Magdalena Moțoi ◽  
Alina Cristina Neguț ◽  
Luminița Bradu ◽  
Daniela Manolache ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Prospective Study ◽  
Viral Hepatitis ◽  
Chronic Viral Hepatitis ◽  
Single Center ◽  
Hepatitis C Treatment ◽  
Viral Hepatitis C ◽  
Chronic Viral Hepatitis C

Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany

2018 ◽  
Vol 35 (4) ◽  
pp. 661-666 ◽  
Author(s):  
Cristina Stasi ◽  
Caterina Silvestri ◽  
Roberto Berni ◽  
Maurizia Rossana Brunetto ◽  
Anna Linda Zignego ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Viral Hepatitis ◽  
Clinical Data ◽  
Chronic Viral Hepatitis ◽  
Viral Hepatitis C ◽  
Chronic Viral Hepatitis C

Chronic viral hepatitis C. Approach to therapy

2021 ◽  
Vol 87 (1) ◽  
pp. 37-41
Author(s):  
T. Ye. Makarova ◽  
◽  
N.N. Dudareva ◽  
N.N. Poletaeva ◽  
E.A. Medvedeva ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Hepatitis C ◽  
Viral Hepatitis ◽  
Chronic Viral Hepatitis ◽  
Viral Hepatitis C ◽  
High Incidence ◽  
Chronic Viral Hepatitis C

The problem of chronic viral hepatitis C currently remains relevant due to the high incidence, frequent outcomes in liver cirrhosis, high disability of the population, and expensive treatment. The article discusses timely approaches to the treatment of chronic viral hepatitis C, using interferon-free therapy regimens.

Sign in / Sign up

Export Citation Format

Share Document